Saccharomyces cerevisiae cells express a family of transcription factors belonging to the basic regionleucine zipper family. Two of these proteins, yAP-1 and Gcn4p, are known to be involved in oxidative stress tolerance and general control of amino acid biosynthesis, respectively. Strains lacking the YAP1 or GCN4 structural gene have very different phenotypes, which have been taken as evidence that these transcriptional regulatory proteins control separate batteries of target genes. In this study, we provide evidence that both yAP-1 and Gcn4p control the expression of a putative integral membrane protein, Atr1p. Both yAP-1 and Gcn4p can elevate resistance to 3-amino-1,2,4-triazole and 4-nitroquinoline-N-oxide but only if the ATR1 gene is intact. Expression of ATR1 is enhanced in the presence of constitutively active alleles of YAP1 and GCN4. Regulation of ATR1 transcription by yAP-1 and Gcn4p occurs through a common DNA element related to the yAP-1 recognition element found upstream of other yAP-1-regulated genes. These data provide the first indication of overlap between the regulatory networks defined by yAP-1 and Gcn4p.
The yeast Saccharomyces cerevisiae possesses a group of sequence-specific transcription factors characterized by the presence of the basic region-leucine zipper or bZip domain as their DNA binding motif (1) . This family of proteins includes the proteins Sko1p/Acr1p (2, 3), Cad1p/yAP-2 (4 -7), Gcn4p (8, 9) , and yAP-1 (10) . In terms of the in vivo role of these factors, the most information is available for Gcn4p and yAP-1. Gcn4p is involved in regulating the transcription of genes encoding enzymes involved in biosynthesis of amino acids and nucleotides (reviewed in Ref. 11 ), while yAP-1 transcriptionally controls the expression of loci involved in oxidative stress tolerance (12, 13) and drug resistance (4, 6, 14) . This information is consistent with the belief that Gcn4p and yAP-1 control the expression of very different sets of genes.
Previous work on the function of a S. cerevisiae protein encoded by the ATR1 locus suggests a possible overlap between Gcn4p and yAP-1. ATR1 was isolated as a gene that suppressed the 3-amino-1,2,4-triazole (3-AT) 1 hypersensitivity of a ⌬gcn4 strain when carried on a high copy plasmid (15) . ATR1 gene expression was suggested to be under Gcn4p control and evidence was presented that Atr1p might mediate 3-AT efflux (15) . ATR1 was shown to be allelic with SNQ1 (16), a member of a set of loci that elevated resistance to the DNA-damaging agent 4-nitroquinoline-N-oxide (4-NQO) when carried on a high copy plasmid. In the same high copy screen that identified ATR1 as a 4-NQO resistance gene (17) , a locus designated SNQ3 was recovered. SNQ3 was later found to be identical to YAP1 (18) . Genetic experiments argued that high copy YAP1-containing plasmids were able to suppress the 4-NQO hypersensitive phenotype of an atr1 strain (19) . This led to the prediction that these loci defined separate 4-NQO resistance pathways (19) .
In this work, we have reexamined the relationship among Gcn4p, yAP-1, and ATR1 gene expression. Contrary to a previous report (19) , we find that yAP-1 is not able to influence 4-NQO tolerance unless the ATR1 gene is present on the chromosome. This observation argues that ATR1 is a target gene of yAP-1. Additionally, yAP-1 provides a major component of 3-AT resistance through its activation of ATR1 gene transcription. DNA binding experiments demonstrate that yAP-1 and Gcn4p bind to the same DNA element in the ATR1 promoter. These data indicate that ATR1 is a gene regulated by the two different bZip transcription factors, yAP-1 and Gcn4p. ATR1 is the first S. cerevisiae gene known that is transcriptionally regulated by these two regulatory proteins. This suggests the possibility that there may be functional overlap in the roles of yAP-1 and Gcn4p in the cell.
MATERIALS AND METHODS
Yeast Strains and Media-Genotypes of the yeast strains used in this study are listed in Table I . Yeast transformations were carried out using the alkali cation technique (20) , and ␤-galactosidase activity assays were performed as described previously (21) . Yeast strains were propagated and tested for drug resistance on minimal SD medium (22) containing the appropriate supplements for growth of auxotrophic strains or rich YPD medium, which consists of 2% yeast extract, 1% peptone, and 2% glucose. Drug resistance assays were performed by spot test assay (4) . HIS3ϩ strains were produced from their his3⌬-200 parents by transformation of the 1.8-kilobase pair HIS3 fragment (23) with selection for HIS3ϩ transformants. HIS3ϩ derivatives were used to test for 3-AT resistance phenotypes. Correct replacement of the his3⌬-200 allele was confirmed by Southern blot analysis (24) .
Plasmids-YEp351-YAP1 and pJAW101 are 2-m plasmids containing either the wild-type YAP1 gene cloned into YEp351 (25) or the wild-type CAD1 gene under the control of the ADH1 promoter cloned in pRS424, respectively. The constitutively active form of GCN4 was constructed by transferring a SalI/EcoRI fragment from p238 (26) into the low copy vector pRS314 (27) . The resulting recombinant was designated pSC6. The GCN4 allele in p238 lacks the translational control signals that normally modulate Gcn4p synthesis (28) . This mutant form of GCN4 causes the protein to be constitutively produced. The constitutively active form of yAP-1 (CSE629AAA) was produced by replacement of the three amino acids cysteine-serine-glutamate (residues 629 -631 * This work was supported by a grant from the American Heart Association and National Institutes of Health Grant GM49825. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
‡ An Established Investigator of the American Heart Association. To whom correspondence should be addressed. Tel.: 319-335-7874; Fax: 319-335-7330; E-mail: moyerowl@blue.weeg.uiowa.edu. 1 The abbreviations used are: 3-AT, 3-amino-1,2,4-triazole; 4-NQO, 4-nitroquinoline-N-oxide; ARE, AP-1 recognition element; YRE, yAP-1 recognition element; SD medium, synthetic dextrose medium; YPD in yAP-1) with three alanine residues (29) . This mutant form of yAP-1 was carried on a low copy plasmid vector, pRS315 (27) . A plasmid bearing the wild-type ATR1 gene was generated by inserting the ATR1 gene as a SacI/EcoRI fragment from pAH21 (30) into pRS316 to form pSC8. The ATR1 gene containing a YRE mutation in the promoter (pSC18) was generated by transferring the altered YRE into the context of the otherwise wild-type structural gene as a SacI/SnaBI fragment.
The wild-type ATR1-lacZ reporter fusion (pET5) was constructed by transferring a XhoI/BglII fragment from pET21 into SalI/BamHI-digested YCpSalZI (31) . The plasmid pET21 was generated by PCR using the primers CCC TCG AGA ATA GTA AGA GAC CAG TAA AG and CCA GAT CTC CCA TTA TTA TTA CCT GTT TG. The resulting PCR product corresponds to ATR1 sequence from Ϫ713 to ϩ179 (numbered relative to transcription start site). This DNA fragment contains the ATR1 promoter and introduces a new BglII site downstream of the ATG. The mutant ATR1 promoter lacking the YRE was generated using a PCR strategy (32) . The primer used to alter the YRE (CAT TCC ATT AGT AgatctT ATA TTA TTT AG) incorporated a new BglII site to facilitate identification of the mutant promoter. The nucleotides replaced by these mutations and the location of the new restriction enzyme site are denoted by lowercase letters and underlining, respectively. The altered promoter was introduced into pET5 as a SacI/SnaBI fragment (pSC21) to generate the mutant YRE reporter fusion.
The oligonucleotides synthesized to test for upstream activation site function of the ATR1 YRE had the following sequences: top, GAT CCA ATA TAG TGA TTA CTA ATG GAA; bottom, GAT CTT CCA TTA GTA ATC ACT ATA TTG. The underlined residues corresponded to the YRE. These oligonucleotides were annealed and cloned into BglII-digested pLG⌬BS in both orientations.
DNase I Protection Assay-Polymerase chain reaction products of the wild-type or mutant ATR1 promoter that contain the YRE region were cloned into pBluescript KSII ϩ . These plasmids were cleaved with EcoRI, treated with calf intestinal alkaline phosphatase, and then phosphorylated with T4 polynucleotide kinase and [␥-32 P]ATP. Each template was then cleaved with XhoI, and the appropriate labeled fragment was isolated from an agarose gel. DNase I protection was performed using bacterially expressed yAP-1 and Gcn4p (10) .
Electrophoretic Mobility Shift Assay-Total protein extracts from S. cerevisiae were prepared by glass bead lysis as described previously (13) , except that the breaking buffer consisted of 300 mM sorbitol, 100 mM NaCl, 5 mM MgCl 2 , 10 mM Tris (pH 7.4), and 1 ϫ complete protease inhibitors (Boehringer Mannheim). Extracts were made from 40 ml of yeast culture grown in YPD medium to an A 600 of 0.6 and then used for the electrophoresis mobility shift assay (EMSA). Bacterially produced Gcn4p was generated as before (33) . Two different oligonucleotides were used. The ATR1 YRE is described above, while the SV40 AP-1 recognition element (ARE) has the following sequence: top, GATCCAT-GGTTGCTGACTAATTGA; bottom, GATCTCAATTAGTCAGCAACCA-TG. The underlined sequence corresponds to the ARE. Oligonucleotides were annealed and labeled with [␥-32 P]ATP by T4 polynucleotide kinase. Each binding reaction contained 1 ng of probe, 2 g of poly(dI-dC) competitor, and 30 g of total extract or 1 l of bacterially expressed Gcn4p. Binding was allowed to proceed at room temperature for 15 min, and samples were then resolved by electrophoresis through a 5% nondenaturing polyacrylamide gel prepared in 1 ϫ TBE (100 mM Tris borate (pH 8), 2 mM EDTA) buffer. Positions of the protein-DNA complexes were detected by autoradiography.
Gene Disruption-A gene disruption of ATR1 was constructed using the one-step disruption method of Rothstein (34) . The starting plasmid for construction of the disruption allele was pET4, which contained an ATR1 HindIII fragment from Ϫ732 to ϩ1743 cloned into pBluescript KSII ϩ . This plasmid was cleaved with NcoI-NdeI, releasing a 307-base pair fragment corresponding to nucleotides from ϩ690 to ϩ996. NcoINdeI-cut pET4 was then treated with the Klenow fragment and the four dNTPs, followed by insertion of a BglII linker to yield the plasmid pET6. A 4.3-kilobase pair BamHI-BglII fragment from pNKY51 (35) was inserted into the BglII linker of pET6. The resulting plasmid (pET10) contained the hisG-URA3-hisG cassette in place of the 307-base pair internal segment of the ATR1 coding sequence. The plasmid pET10 was digested with XhoI and XbaI and transformed into the yeast strain SEY6210. Appropriate recombinants were identified by Southern blotting (24) , and the URA3 gene was cured by treatment with 5-fluoroorotic acid as described by Boeke et al. (36) .
RESULTS
The resistance spectrum of yAP-1 overlaps that of Atr1p. In a systematic search for genes that conferred high level resistance to 4-NQO when present on a high copy plasmid, 2-m plasmids carrying YAP1, SNQ2, or SNQ1 were found to be able to strongly elevate 4-NQO tolerance (17) . SNQ1 was later shown to be allelic with ATR1, a gene isolated by its ability to suppress the hypersensitivity of gcn4 strains to the competitive inhibitor of histidine biosynthesis, 3-AT (15) . We evaluated the ability of yAP-1 to confer resistance to 3-AT as a first step in testing the hypothesis that yAP-1 might confer tolerance to both 3-AT and 4-NQO through control of ATR1/SNQ1 gene expression.
A strain lacking the YAP1 locus was transformed with a low copy plasmid expressing wild-type yAP-1 or a gain-of-function mutant form of the protein (CSE629AAA). The CSE629AAA form of yAP-1 behaves as a constitutively active positive regulator of transcription, while the wild-type protein cycles between states of high and low activity, depending on environmental cues (29) . The low copy vector plasmid was also transformed as a control. Appropriate transformants were placed on media containing 3-AT or 4-NQO and assayed for the ability to grow (Fig. 1) .
The mutant YAP1 locus encoding the CSE629AAA form of the protein supported resistance at the highest levels of 3-AT or 4-NQO tested. The wild-type YAP1 gene was able to permit growth at the lower concentrations of drugs tested, while ⌬yap1 cells carrying the vector plasmid alone were strongly inhibited by the presence of either 3-AT or 4-NQO. These data are consistent with the notion that yAP-1 could act through ATR1 to confer resistance to both 3-AT and 4-NQO, since overproduction of Atr1p also leads to resistance to these same two compounds (16). This model predicts that loss of the ATR1 locus should decrease or eliminate the ability of yAP-1 to affect resistance to these two compounds. This prediction was tested by transforming atr1 cells with a high copy YAP1 plasmid and determining drug resistance of the resulting transformants.
Overexpression of YAP1 Does Not Rescue the 3-AT and 4-NQO Hypersensitivity of ⌬atr1
Cells-It has previously been reported that deletion of the ATR1 gene results in cells that are hypersensitive to 3-AT (15) and 4-NQO (16). One group also reported that overproduction of SNQ3 (YAP1) in a snq1 (atr1) background still led to a 4-NQO hyperresistant phenotype (19) . We constructed an ⌬atr1 strain that is isogenic with our wildtype strain by one-step gene disruption (34) . The wild-type and ⌬atr1 strains were then transformed with a high copy vector or (Fig. 2) . Transformants carrying the 2-m plasmid containing YAP1 exhibited a large increase in the ability to tolerate both drugs. However, this increase in drug resistance was strictly dependent on the presence of the ATR1 gene. Loss of ATR1, even in cells overproducing yAP-1, led to a 3-AT-and 4-NQO-hypersensitive phenotype. These results differ from a previous study (19) where overproduction of yAP-1 was able to suppress the 4-NQO-hypersensitive phenotype of an atr1 mutant. The reason for the difference between our data and the data of others (19) may be due to differences in the strains, atr1 alleles, or media conditions used. These data are consistent with a model invoking yAP-1 as an upstream regulator of ATR1, which in turn more directly affects drug resistance. Taken together, these observations provide genetic evidence that yAP-1 confers 3-AT and 4-NQO resistance through activation of the ATR1 promoter. To provide molecular support for this model, we examined the ATR1 promoter for elements to which yAP-1 could bind and regulate transcription.
Comparison of DNA Sites Known to Bind yAP-1 and the Putative ATR1 yAP-1 Recognition Element-By computer analysis, we searched the ATR1 promoter for sequence motifs that could serve as a yAP-1 recognition element (YRE). The alignment in Fig. 3 shows the comparison of a potential YRE in the ATR1 promoter with known YREs from the GSH1, YCF1, TRX2, and GLR1 genes in S. cerevisiae. The AP-1 recognition element in the SV40 early enhancer is also shown for comparison, since this site was the first binding motif shown to function in a YAP1-dependent fashion in S. cerevisiae (31) . An ATR1 promoter element was found that showed high sequence identity to the other known YREs. This DNA segment provides a candidate element for the site of action of yAP-1 at the ATR1 promoter. This potential yAP-1 binding site is located 228 base pairs upstream of the start site for ATR1 gene transcription, in a reasonable location to serve as an upstream activation sequence for ATR1 expression. To test the function of this putative YRE, we evaluated the ability of bacterially produced yAP-1 to bind this site.
Bacterially Produced yAP-1 and Gcn4p Bind the ATR1 YRE-We produced yAP-1 and Gcn4p in bacterial expression systems to determine if either/both of these bZip transcription factors would bind to the putative ATR1 YRE. Previous work of Kanazawa et al. (15) provided evidence that ATR1 might be a downstream target of Gcn4p. A radiolabeled ATR1 DNA template, containing the putative YRE, was used as the template in a DNase I protection experiment assay. Bacterially produced yAP-1 and Gcn4p were used as input proteins to evaluate their relative abilities to protect the ATR1 promoter DNA from DNase I cleavage.
As can be seen in Fig. 4 , inclusion of either bacterially expressed yAP-1 or Gcn4p led to protection of a region in the ATR1 promoter that corresponded to the YRE. To evaluate the role of the nucleotides corresponding to the putative YRE in yAP-1 and Gcn4p DNA binding, a clustered base substitution mutation in the ATR1 YRE was prepared and used in the DNase I protection assay. Loss of these nucleotides in the YRE prevented binding of both yAP-1 and Gcn4p to the YRE. These data suggest that both yAP-1 and Gcn4p bind to the same DNA element in the ATR1 promoter.
ATR1 Expression Responds to Gene Dosage of YAP1 and GCN4 -To determine if the ability of yAP-1 and Gcn4p to bind to the ATR1 promoter translated into an effect on in vivo regulation of ATR1, the expression of an ATR1-lacZ gene fusion was evaluated in strains with different gene dosages of YAP1 and/or GCN4. The ATR1-lacZ fusion gene, containing 713 base pairs of ATR1 5Ј-flanking DNA upstream of the transcription start site, was introduced into appropriate S. cerevisiae strains, and the ␤-galactosidase activity was determined (Table II) . FIG. 2. YAP1-mediated 3-AT and 4 -NQO resistance requires the presence of the ATR1 structural gene. An isogenic pair of wild-type and ⌬atr1 cells was transformed with a high copy vector plasmid (YEp351) or the same plasmid carrying the wild-type YAP1 gene (YEp351-YAP1). Since both yeast strains contained a wild-type chromosomal copy of YAP1, the dosage of this locus varied from wild type (when YEp351 was present) to high copy (when YEp351-YAP1 was present). Selected transformants were tested for drug resistance using the spot test assay as described in the legend to Fig. 1.   FIG. 3 . Alignment of known yAP-1 recognition elements in S. cerevisiae genes. A computer alignment of yAP-1 recognition elements found in several different S. cerevisiae promoters is shown. Experimental evidence has been obtained to indicate the role of each element in yAP-1-mediated transcriptional control of each relevant promoter (see text). The shaded residues correspond to sequence identities between the different sites. A possible consensus sequence for yAP-1 binding is shown at the bottom along with the known binding motif for Gcn4p (46) .
The ATR1-lacZ reporter fusion present in wild-type cells produced 5 units/A 600 of ␤-galactosidase activity. Removal of either the YAP1 or GCN4 gene reduced ATR1-dependent expression to 1.7 and 2.4 units/A 600 , respectively. A strain lacking both YAP1 and GCN4 produced only 1.1 units/A 600 of activity. The introduction of a multicopy plasmid overproducing yAP-1 elevated production of ␤-galactosidase activity to 16 units/A 600 . A low copy plasmid carrying a constitutively active form of the GCN4 locus increased ATR1-dependent enzyme activity to 11 units/A 600 . No effect on ATR1 expression was seen in response to changing the gene dosage of the CAD1 locus, a gene encoding a bZip protein related to yAP-1 and Gcn4p (4 -7).
To determine if the YRE was required for the observed effect of yAP-1 and Gcn4p on ATR1 gene expression, a mutant form of the ATR1-lacZ fusion gene was prepared using the clustered base substitution in the YRE. Neither yAP-1 or Gcn4p was able to bind to this mutant YRE in vitro (Fig. 4) . This mutant YRE-containing ATR1-lacZ fusion gene (mYRE-ATR1-lacZ) was transformed into cells along with a low copy vector plasmid or low copy plasmids carrying constitutively active alleles of YAP1 (CSE629AAA) or GCN4 (GCN4 c ). The wild-type ATR1-lacZ fusion was assayed in parallel as a control for the behavior of the normal locus (Table III) . Loss of the YRE blocked the ability of the constitutive alleles of either YAP1 or GCN4 to normally stimulate expression of ATR1.
These data indicate that both yAP-1 and Gcn4p act to stimulate expression of ATR1. Additionally, the transactivation of ATR1 by both yAP-1 and Gcn4p requires the YRE. The phenotypic effects of loss of the YRE from the ATR1 promoter were next evaluated.
3-AT and 4-NQO Resistance Phenotypes of the ATR1 Promoter Mutants-
To examine the phenotypic consequences of the mutations in the ATR1 YRE, the clustered base substitution mutation was transferred into the context of the wild-type ATR1 gene. A ⌬atr1 (SCY2) yeast strain was transformed with a low copy number plasmid bearing the wild-type or the mutant YRE-containing ATR1 gene. Along with the plasmids containing the two different ATR1 alleles, a low copy vector plasmid or this same plasmid expressing constitutively active forms of YAP1 or GCN4 was also introduced. The resulting transformants were assayed for their ability to complement the 3-AT-and 4-NQO-hypersensitive phenotype of the ⌬atr1 strain (Fig. 5) .
Transformants containing the wild-type ATR1 gene (pSC8) were able to grow normally on both 3-AT and 4-NQO. The constitutively active alleles of both YAP1 and GCN4 produced elevated resistance to both of these chemicals in the presence of the wild-type ATR1 locus. However, transformants carrying an ATR1 gene with a mutant YRE could not grow as well on either cytotoxic agent as those containing an ATR1 allele with a wild-type YRE. Moreover, the mutations in the YRE blocked the hyperresistance conferred by the constitutively active YAP1 and GCN4 alleles. These data indicate that the YRE is necessary for the YAP1-and GCN4-dependent resistance to 3-AT and 4-NQO conferred by ATR1.
The ATR1 YRE Functions as an Upstream Activation Sequence When Placed Upstream of a Heterologous Promoter-To
determine if the ATR1 YRE was sufficient to serve as an upstream activation sequence in S. cerevisiae, the UAS region of a CYC1-lacZ fusion gene was replaced with an oligonucleotide corresponding to the ATR1 YRE. The ATR1 YRE oligonucleotide was fused to CYC1-lacZ in each of the two possible orientations, and the resulting fusion plasmids were transformed into isogenic wild-type, ⌬yap1, ⌬gcn4, and ⌬yap1,gcn4 strains. ␤-Galactosidase activities were determined for each transformant (Table IV) .
The YRE-CYC1-lacZ gene fusions were able to produce 4.8-fold (pSC2) and 3.3-fold (pSC11) more activity then that of the vector only (pLG⌬BS) in the wild-type background. Loss of the YAP1 gene reduced the level of YRE-stimulated ␤-galactosid-
Recognition of a common element in the ATR1 promoter by yAP-1 and Gcn4p. The ability of bacterially produced yAP-1 or Gcn4p to bind to the ATR1 promoter was assessed by DNase I protection analysis. DNA templates corresponding to the wild-type (wtYRE) or mutant (mYRE) ATR1 promoters were labeled with 32 P and incubated with 1 or 5 l (denoted by the increasing width of the bar) of recombinant yAP-1 or Gcn4p. Protein was omitted from the reaction as a control (no protein). The radiolabeled wild-type ATR1 template was subjected to the purine-and pyrimidine-specific Maxam-Gilbert chemical sequencing reactions (AG and CT, respectively) to allow the location of the binding site to be determined. The bound promoter DNA segments are shown on the left side with the size of protected areas indicated by the bars. The boldface sequence motif corresponds to the location of the YRE. 
a Only the alleles of the bZip-encoding genes of interest are shown. b Values represent ␤-galactosidase activities that were determined and reported as described previously (21) . Cells were grown in SD medium containing appropriate supplements. 
a The indicated fusion genes contained either wild-type (ATR1-lacZ) or mutant (mYRE-ATR1-lacZ) versions of the ATR1 YRE.
b ␤-Galactosidase activities produced by the indicated fusion genes present in wild-type cells along with a low copy vector or constitutively active alleles of YAP1 (CSE629AAA) or GCN4 (GCN4 c ) were determined and reported as described above.
ATR1 Coregulation by yAP-1 and Gcn4p
ase expression produced by either reporter plasmid. Removal of the GCN4 gene had no significant effect on the transactivation supported by the ATR1 YRE, as long as the YAP1 gene was still present. The contribution of Gcn4p to ATR1 YRE function could clearly be seen in a strain lacking both YAP1 and GCN4. This double mutant strain produced ␤-galactosidase levels that were essentially the same as those of the CYC1-lacZ fusion gene lacking any UAS. This analysis suggests that, under these conditions, yAP-1 is the major contributor to YRE-mediated transactivation of ATR1. These data also indicated that the ATR1 YRE was able to act as an orientation-independent UAS that is responsive to yAP-1 levels in the cell.
The Relative Affinity of yAP-1 Is Higher Than Gcn4p for the ATR1 YRE-The data presented here indicate that yAP-1 has a quantitatively greater role in ATR1 expression than Gcn4p. One possible explanation for this greater effect of yAP-1 on ATR1 expression is that yAP-1 has a higher relative affinity for the YRE than does Gcn4p. To investigate this possibility, we carried out electrophoretic mobility shift assays (EMSAs) to compare the affinities of yAP-1 and Gcn4p for the ATR1 YRE. Oligonucleotides corresponding to the ATR1 YRE and the SV40 ARE were radiolabeled and used in EMSA to investigate the relative affinities yAP-1 and Gcn4p (Fig. 6) .
Formation of a yAP-1⅐YRE complex is completely abolished in the presence of a 10-fold molar excess of unlabeled YRE, while Gcn4p⅐YRE binding can be detected easily at this excess of YRE. Strikingly, the yAP-1⅐ARE complex is eliminated in the presence of a 3-fold molar excess of the YRE, while the Gcn4p⅐ARE complex can still be detected in the presence of a 25-fold molar excess of YRE. These data argue that the relative affinity of yAP-1 for the ATR1 YRE is higher than that of Gcn4p.
DISCUSSION
The observation that both yAP-1 and Gcn4p control expression of ATR1 was not expected based on the phenotypes of strains lacking these transcription factors. Cells lacking the GCN4 gene are defined by hypersensitivity to a large variety of amino acid analogs (11) , while yap1 mutants are unable to tolerate oxidative stress (12) . Our previous study of S. cerevisiae GSH1 gene expression, a yAP-1 target gene, demonstrated that GCN4 did not contribute to expression of this locus (32) . The work presented here establishes that while there are clear differences between the identity of genes regulated by yAP-1 and Gcn4p, ATR1 provides an example of a locus at which these regulatory networks overlap. To our knowledge, this is the first example of a gene responsive to these two different bZip transcription factors.
While changing YAP1 or GCN4 gene dosages has clear effects on ATR1 expression, the quantitative alterations in ATR1-dependent ␤-galactosidase levels are relatively small (Table II) . In the yAP-1-and Gcn4p-regulated genes that have been examined, these modest changes in expression are the rule rather than the exception (11, 13, 32, 37, 38) . Additionally, the data presented here argue that both yAP-1 and Gcn4p contribute to ATR1 expression under normal growth conditions (Table II) . We suggest that wild-type ATR1 transcription levels result from the combined action of yAP-1 and Gcn4p at the ATR1 promoter. Furthermore, evidence presented in this paper argues that yAP-1 may be the more important regulator of ATR1 and has a higher affinity for the ATR1 YRE.
Why would both yAP-1 and Gcn4p regulate expression of ATR1? One possible answer to this question comes from consideration for a role of Gcn4p in stress tolerance. In a study of the response to ultraviolet light in S. cerevisiae, it was shown that the presence of the GCN4 gene was required for normal tolerance of ultraviolet light exposure (39) . The involvement of yAP-1 in stress tolerance has been established by several different groups (4, 6, 7, (12) (13) (14) . Perhaps Gcn4p has a wider role in metabolic control of gene expression and is involved in stress tolerance in a broader sense than previously thought.
The fact that both yAP-1 and Gcn4p act to stimulate 3-AT resistance through ATR1 is striking in light of what is known of the action of 3-AT in S. cerevisiae. The best known effect of 3-AT in S. cerevisiae is the competitive inhibition of the HIS3 gene product that leads to histidine starvation (40) . This property of 3-AT has been routinely used to generate mutations that define loci regulating GCN4 expression (Reviewed in Ref. 28 ). However, 3-AT also serves as an inhibitor of catalase activity, and this property has been exploited to isolate mutants defective in production of the peroxisomal catalase protein (41). 3-AT has multiple actions in the cell, and normal resistance to this compound requires the activity of both yAP-1 and Gcn4p. FIG. 5 . The yAP-1 recognition element is required for normal ATR1 gene function. A ⌬atr1 strain (SCY2) was transformed with a low copy plasmid carrying either the wild-type ATR1 gene or a mutant variant lacking the YRE. The presence of the normal YRE in the plasmid-borne copy of ATR1 is indicated at the top of each panel as YRE ϩ, while the presence of the mutant YRE is denoted as YRE Ϫ. Along with each ATR1 derivative, a second plasmid was introduced corresponding to a low copy vector plasmid or the same vector plasmid carrying a constitutively active form of either YAP1 (CSE629AAA) or GCN4 (GCN4 c ). The vector plasmids used were either pRS315 for YAP1 or pRS314 for GCN4. Appropriate transformants were assayed for drug resistance by spot test assay. a The lacZ gene fusion responsible for the observed ␤-galactosidase activity is listed.
b A single copy of the ATR1 YRE was inserted in the same (forward) or opposite (reverse) orientation relative to the CYC1 promoter as in the ATR1 promoter.
c ␤-Galactosidase activities produced by the indicated fusion genes present in isogenic wild-type or ⌬yap1 transformants were determined and reported as described above.
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The involvement of yAP-1 in 3-AT tolerance is limited to regulation of ATR1, while Gcn4p must activate expression of HIS3 (42) as well as ATR1 for normal 3-AT tolerance to occur.
Along with the role of Atr1p in tolerance to 3-AT, this protein mediates resistance to 4-NQO. Snq2p, an ATP binding cassette transporter protein (43) , is also involved in 4-NQO resistance. SNQ2 expression is controlled by the Pdr1p and Pdr3p transcriptional regulatory proteins (44, 45) but does not respond to changes in YAP1 gene dosage. 2 Additionally, high copy plasmids carrying ATR1 can suppress the 4-NQO-hypersensitive phenotype of a snq2 strain, and overproduction of Snq2p can suppress the corresponding 4-NQO hypersensitivity of an atr1 mutant strain (19) . 3 Taken together, these data suggest that 4-NQO resistance mediated by yAP-1/Atr1p and Pdr1p/Pdr3p/ Snq2p define separate drug tolerance pathways for this DNAdamaging agent.
The definition of the ATR1 YRE provides important new information as to the nature of authentic yAP-1 response elements in S. cerevisiae. Detailed examination of the DNA binding site for Gcn4p has established the consensus sequence TGA(G/C)TCA as the idealized site for binding of this transcription factor (42, 46) . There have now been five genes that have been shown to be under yAP-1 regulation: GSH1 (32), TRX2 (13), YCF1 (38) , GLR1 (37) , and now ATR1. Alignment of the YREs present in each of these promoters suggests the consensus sequence TTA(G/C)TAA for yAP-1 binding in S. cerevisiae. Since the phenotypes and target genes under control of yAP-1 and Gcn4p are different, these factors cannot recognize identical DNA elements. This different consensus sequence is consistent with the known similarity of structure between these two bZip transcription factors and provides a molecular rationale behind why most yAP-1 and Gcn4p target loci are not regulated by both proteins. It is understandable then that yAP-1 has a higher relative affinity for the ATR1 YRE, while Gcn4p has a higher affinity to the Gcn4p recognition elementlike AP-1 recognition element. Confirmation of this suggested consensus sequence for yAP-1 binding awaits biochemical and genetic studies as carried out for Gcn4p.
The rationale behind the coregulation of ATR1 by yAP-1 and Gcn4p is not likely to be understood until the function of Atr1p is known. The finding that Atr1p acts to increase the efflux of 3-AT (15) suggests that this protein might function as a transporter for this and possibly other compounds such as 4-NQO. The ability to act as a transporter might be the common link that ties Atr1p to the yAP-1 and Gcn4p regulatory responses. Transport of small molecules across membranes is likely to be important in the physiological roles of the genes regulated by either yAP-1 or Gcn4p. Amino acid sequestration in the yeast vacuole is important in maintenance of amino acid pools in the cell (47, 48) , and Gcn4p acts to oppose changes in these intracellular amino acid pools (11) . We have already provided evidence (38) A. EMSA using the ATR1 YRE as the probe. The increasing width of the bar corresponds to increasing molar ratio of competitor to probe (10-, 25-, 50-, and 100-fold). B, the SV40 ARE was used as the probe. The increasing concentrations of ATR1 YRE competitor (3-, 5-, 10-, and 25-fold) are indicated as in A. In both panels, a yAP-1 monoclonal antibody (yAP-1 mAb) was used to supershift the yAP-1-containing protein-DNA complex. EMSA was also performed on a protein extract from a ⌬yap1 yeast strain.
